Fly Play hf.: Candidates for the Board of Directors of Fly Play hf. at the AGM on 7 March 2023
The following individuals have declared their candidacy to the board of directors of Fly Play hf. at the Annual General Meeting 2023 at Iðnó, on March 7, at 16:00.
As the Annual General Meeting elects five members to the board of directors and one alternate board member, these candidates will be elected to the board without a ballot at the meeting.
Einar Örn Ólafsson, current Chairman
Einar Örn Ólafsson is the current chairman of the board of PLAY. He is also the chairman of the board of Terra hf. and the CEO of the investment company Gnitanes hf. Einar was previously the CEO of Fjarðalax and CEO of Skeljungur, and before that, he held various management positions in finance.
Einar holds an MBA from NYU, Stern School of Business, and an industrial engineering degree from the University of Iceland.
Einar Örn is considered to be independent of the Company and its management team but is not considered to be independent of large shareholders in the Company.
Elías Skúli Skúlason, current Vice Chairman
Elías Skúli Skúlason (Skúli) is the vice chairman of the board of directors of PLAY.
Skúli has over 25 years of aviation and airline operations experience. Elías Skúli was one of the founders of Airport Associates (est. in 1997) and Bluebird Cargo (est. in 1999). Skúli served in multiple key management roles at Bluebird Cargo, including CEO from 2007-2014. Skuli is an investor whose investments include a shareholding in FEA ehf.
Elías Skúli is considered independent from large shareholders of the Company and its management team but is not regarded as independent of the Company.
Guðný Hansdóttir, current Board Member
Guðný is currently a member of the board of PLAY. She has over 15 years of experience in the airline industry. Guðný served as a Managing Director of cabin crew for Icelandair. She served as VP of Human Resources at Air Atlanta for five years. Other previous positions include Foreign Marketing coordinator at Penninn Officeday and VP of Human Resources for Skeljungur and Innnes.
Guðný holds an MBA from the Florida Institute of Technology and a BS in Marketing from the same school. Guðný has been vetted through an eligibility assessment by the Financial Supervisory Authority in Iceland. Guðný sat on the boards of Parlogis and Mjöll Frigg. She is currently a board member of Frumherji and VÍS Insurance and on the latter's Remuneration Committee and Auditing Committees.
Guðný is considered to be independent of the Company, its management team, and large shareholders in the Company.
María Rúnarsdóttir, current Board Member
María Rúnarsdóttir is currently a member of the board of PLAY. She is an independent investor. María previously worked as the CFO of real estate company SMI ehf. and Korputorg ehf., a consultant at KMPG Consultants and CFO of Svar technologies. She was also one of the founders of MINT Solutions ehf. María currently sits on the board of numerous companies, including Arctica Finance hf., MINT Solutions BV., Umbra ehf., Uniconta Iceland ehf., NMR ehf., and EA14 ehf.
María has an MBA from MIT (Massachusetts Institution of Technology) in the United States and a BSc in Business from Reykjavik University.
María is considered to be independent of the Company, its management team, and large shareholders in the Company.
Valentín Lago, new board member
Valentín Lago will be a new member of the board of directors of PLAY. Valentín has 30 years of experience in Aviation & Aerospace. He has held several management, executive & board positions in; regional airlines (Quality, Maintenance Director of Air Nostrum 1998-2011), low-cost airlines (Founder & COO of Iberia Express 2011-2016, COO of Vueling 2016-2019), and transatlantic airlines (CEO of Air Europa 2021-2022). Currently, Valentin has his own Consultancy firm.
Valentín holds a degree in aerospace engineering and a Ph.D. in Economics.
Valentín is considered to be independent of the Company, its management team, and large shareholders in the Company.
Alternate Board Member: Sigurður Kári Kristjánsson,
Sigurður Kári is currently an alternate member of the board of PLAY. He is an independent attorney at law and a partner of the law firm Lögmenn Lækjargötu, where he has practiced law since 2011. Sigurður Kári was a member of parliament from 2003-2009 and served intermittently as an alternate member of parliament until 2011.
Sigurður Kári is considered to be independent of the Company, its management team, and large shareholders in the Company.
Further information:
ir@flyplay.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Aduro Clean Technologies Increases Size of Private Placement to $4 Million29.3.2023 02:12:40 CEST | Press release
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SARNIA, Ontario, March 28, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based technologies to chemically recycle plastics, and to transform heavy crude and renewable oils into feedstocks and higher-value fuels, is pleased to announce that, further to its news release dated March 8, 2023, it has increased the size of its non-brokered private placement of units (the “Units”) at $0.93 per Unit for gross proceeds of a minimum of $1,999,965 and up to a maximum of $4,000,000 (the “LIFE Offering”). Each Unit will consist of one (1) common share in the capital of the Company (each, a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable into one (1) Common Share (each, a “Warrant Share”) at a price o
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform28.3.2023 22:05:00 CEST | Press release
SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi-year licensing agreement of intellectual property from UC San Francisco (UCSF) through its Innovation Ventures group to develop and commercialize a radially branching cellular delivery device for use both in the Operating Room under fluoroscopy/CT guidance and under MRI guidance. “This invention will help clinicians guide the delivery of biologic therapies — from stem cell transplants to gene therapy vectors — to specific locations in the human brain with real-time image guidance,” said Dr. Daniel Lim, MD, PhD, Professor of Neurological Surgery at UCSF. “By helping surgeons tailor biologic delivery to individual patient anatomy and specific diseases, I hope that this invention can contribute importantly to the successful treatment of neurological disor
Development of the Annual General Meeting of the BANK of Greenland28.3.2023 22:03:19 CEST | Press release
Minutes of General Meeting To Nasdaq OMX Copenhagen 28 March 2022 Company announcement no. 05/2023 Development of the Annual General Meeting of the BANK of Greenland Today, the BANK of Greenland held its Annual General Meeting in accordance with the Articles of Association and the previously published notice convening the meeting. The Annual General Meeting was attended by shareholders representing 1,049,468 votes, of which 612,498 votes were given by proxy to the Board of Directors, 62,821 votes were covered by instructions to holders of power of attorney and 115,455 votes of correspondance. The Board of Directors' Report on the Bank's activities during the past year The Chairman of the Board of Directors Gunnar í Liða presented the Board of Directors' report on the Bank's activities during the past year. The report of the Board of Directors was noted. The Chairman's report can be viewed on the Bank's website at www.banken.gl. The minutes of the Annual General Meeting will also be pub
Forløb af ordinær generalforsamling i GrønlandsBANKEN28.3.2023 22:03:19 CEST | pressemeddelelse
Referat af Generalforsamling Til Nasdaq OMX Copenhagen 28. marts 2023 Selskabsmeddelelse nr. 05/2023 Forløb af ordinær generalforsamling i GrønlandsBANKEN GrønlandsBANKEN har i dag afholdt ordinær generalforsamling i henhold til vedtægterne og tidligere offentliggjort indkaldelse. Generalforsamlingen var repræsenteret med 1.049.468 stemmer, heraf var 612.498 stemmer givet som fuldmagt til bestyrelsen, 62.821 stemmer var givet som instruktionsfuldmagt, mens 115.455 var afgivet som brevstemme. Bestyrelsens beretning om bankens virksomhed i det forløbne år Bestyrelsesformand Gunnar í Liða aflagde bestyrelsens beretning om bankens virksomhed i det forløbne år. Bestyrelsens beretning blev taget til efterretning. Formandens beretning kan ses på bankens hjemmeside www.banken.gl Generalforsamlingens protokollat vil senest 14 dage efter generalforsamlingens afholdelse ligeledes blive lagt på bankens hjemmeside. Godkendelse af årsrapporten for 2022, meddelelse om decharge for bestyrelse og direk
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants28.3.2023 22:00:00 CEST | Press release
Company announcement – No. 8 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 28, 2023 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 34,594 divided into 34,594 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs. Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration. For a more detailed description of Zealand Pharma’s warrant programs, see the company’s Articles of Association, which ar